Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 12/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18074846 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL438900 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL437819 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL437825 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL18074845 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL14454320 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL18074852 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL12587374 | 1.00 | BCHE (0.58) | BCHECA1CA2CES2CES1 | |
| SCHEMBL14665589 | 0.94 | BCHE (0.53) | BCHECA1CA2 | |
| SCHEMBL13822126 | 0.94 | BCHE (0.57) | BCHECA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9987866-B2 | Marking comprising a chiral liquid crystal polymer and a luminescent substance | SICPA HOLDING SA (CH) | 2018-06-05 | — | — | US | disclosed |
| US-20170120649-A1 | MARKING COMPRISING A CHIRAL LIQUID CRYSTAL POLYMER AND A LUMINESCENT SUBSTANCE | SICPA HOLDING SA (CH) | 2017-05-04 | — | — | US | disclosed |
| US-20160272890-A1 | COMPOSITE MARKING BASED ON CHIRAL LIQUID CRYSTAL PRECURSORS AND MODIFYING RESINS | SICPA HOLDING SA (CH) | 2016-09-22 | — | — | US | disclosed |
| US-20160264591-A1 | CHIRAL DOPANT AND IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS | SICPA HOLDING SA (CH) | 2016-09-15 | — | — | US | disclosed |
| US-20160264792-A1 | SALT-FREE COMPOSITE MARKING BASED ON CHIRAL LIQUID CRYSTAL PRECURSORS COMPRISING CHIRAL ACRYLATE DOPANTS | SICPA HOLDING SA (CH) | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264591-A1 | CHIRAL DOPANT AND IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS | CCNT1, CD99, CCNA1 | BCHE 3784/4885CA1 1332/4885CA2 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.